Dr. Panaccione is director of the Inflammatory Bowel Disease Clinic and an associate professor of medicine, both at the University of Calgary in Alberta, Canada. He graduated from the University of Western Ontario (London, Ontario) with a degree in medicine in 1993. He went on to complete his internal medicine and gastroenterology training at the University of Western Ontario and is certified as a fellow of the Royal College of Physicians and Surgeons of Canada in both internal medicine and gastroenterology. Dr. Panaccione completed advanced training in inflammatory bowel disease at the Mayo Clinic in Rochester, Minn. He is presently the medical director for the Crohn's & Colitis Foundation, Calgary Chapter and sits on the medical advisory council for the Crohn's & Colitis Foundation of Canada.Dr. Panaccione's main research interests lie in the fields of advanced immunomodulation and biological therapy. In Canada he is a recognized authority on the use of infliximab and co-authored the guidelines on the use of infliximab for the Canadian Association of Gastroenterology. He actively participates in clinical trials of new therapeutic agents in Crohn's disease and ulcerative colitis.

His other interest is medical education. He has been recognized as a gold star lecturer, small groups leader, and clinical preceptor by the University of Calgary Medical School, and has lectured extensively across North America on various topics in inflammatory bowel disease.

Dr. Panaccione is the author of many peer-reviewed articles and book chapters on inflammatory bowel disease and currently serves as the medical director for the Crohn's and Colitis Foundation Calgary Chapter and sits on the Medical Advisory Council for the Crohn's and Colitis Foundation of Canada.